Welcome to LookChem.com Sign In|Join Free

CAS

  • or

227023-66-7

Post Buying Request

227023-66-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

227023-66-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 227023-66-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,7,0,2 and 3 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 227023-66:
(8*2)+(7*2)+(6*7)+(5*0)+(4*2)+(3*3)+(2*6)+(1*6)=107
107 % 10 = 7
So 227023-66-7 is a valid CAS Registry Number.

227023-66-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name (4-Benzyloxy-5-methoxy-2-nitro-phenyl)-(4-cyano-phenylamino)-acetic acid methyl ester

1.2 Other means of identification

Product number -
Other names methyl (RS)-(4-benzyloxy-5-methoxy-2-nitrophenyl)-(4-cyanophenylamino)acetate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:227023-66-7 SDS

227023-66-7Relevant articles and documents

Design of selective phenylglycine amide tissue factor/factor VIIa inhibitors

Groebke Zbinden, Katrin,Banner, David W.,Ackermann, Jean,D'Arcy, Allan,Kirchhofer, Daniel,Ji, Yu-Hua,Tschopp, Thomas B.,Wallbaum, Sabine,Weber, Lutz

, p. 817 - 822 (2007/10/03)

Proof of concept experiments have shown that tissue factor/factor VIIa inhibitors have antithrombotic activity without enhancing bleeding propensity. Starting from lead compounds generated by a biased combinatorial approach, phenylglycine amide tissue fac

Serine protease inhibitors

-

, (2008/06/13)

Compounds having the structure shown below wherein A, B, N1, N2, X, Y, Q, R2, R5and R6are as defined herein are useful to inhibit serine protease enzymes, such as TF/factor VIIa factor Xa, thrombin and kallikrein. These compounds may be used in methods of preventing and/or treating clotting disorders.

N-(4-carb-amimidophenyl)glycineamide derivatives

-

, (2008/06/13)

N-(4-carbamimidophenylamino) phenylglycineamide derivative compounds having the formula: in which E, g1, g2, Q, R and X1 to X4 are each as defined in the description, and hydrates or solvates and physiologically acceptable salts thereof can be used as inhibitors of the formation of the coagulation factors Xa, IXa and thrombin induced by the factor VIIa and by the tissue factor. These compounds can be used as medicaments for the treatment and/or prevention of thromboses, apoplexy, cardiac infarction, inflammation and arteriosclerosis or as antitumor agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 227023-66-7